Jonathan E. Freeman
CIK: 0001708133
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)3 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PHIO
Phio Pharmaceuticals Corp.
Director
Discretionary Trading P&L
Holdings
About Freeman Jonathan E
Freeman Jonathan E (SEC CIK 0001708133) files insider reports with the SEC as Director of Phio Pharmaceuticals Corp. (PHIO).
Signal8 holds 3 ownership filings by Freeman Jonathan E, all Form 4s, filed between Sep 13, 2024 and Feb 6, 2026. Those filings report 3 transactions, from Sep 11, 2024 to Feb 5, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Freeman Jonathan E's filings is in KING OF PRUSSIA, PA.
Recent filings by Freeman Jonathan E
Other insiders filing for Phio Pharmaceuticals Corp. (PHIO)
- Carson Lisa Cabott, Chief Financial Officer
- Bitterman Robert J, Chairman, Pres. & CEO
- Plott Ronald Todd, Director
- BRADFORD PATRICIA A, Director
- Lockshin Curtis, Director
- Deming David H, Director